These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1514038)

  • 1. Cells from healthy non-exposed individuals produce cytokines to selected fractions of Leishmania promastigotes.
    Maasho K; Akuffo HO
    Scand J Immunol Suppl; 1992; 11():179-84. PubMed ID: 1514038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine responses to parasite antigens: in vitro cytokine production to promastigotes of L. aethiopica by cells from non-Leishmania exposed donors may influence disease establishment.
    Akuffo HO
    Scand J Immunol Suppl; 1992; 11():161-6. PubMed ID: 1514033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma and interleukin-4 production by human T cells recognizing Leishmania donovani antigens separated by SDS-PAGE.
    Bahrenscheer J; Kemp M; Kurtzhals JA; Gachihi GS; Kharazmi A; Theander TG
    APMIS; 1995 Feb; 103(2):131-9. PubMed ID: 7748537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune reactivity to fractionated Leishmania aethiopica antigens during active human infection.
    Laskay T; Mariam HG; Berhane TY; Fehniger TE; Kiessling R
    J Clin Microbiol; 1991 Apr; 29(4):757-63. PubMed ID: 1909712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes.
    Telino E; De Luca PM; Matos DC; Azeredo-Coutinho RB; Meirelles MN; Conceição-Silva F; Schubach A; Mendonça SC
    Clin Exp Immunol; 2006 Feb; 143(2):338-44. PubMed ID: 16412059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural and acquired resistance to Leishmania: cellular activation by Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of natural killer (NK) cells.
    Akuffo H; Maasho K; Howe R
    Clin Exp Immunol; 1993 Dec; 94(3):516-21. PubMed ID: 7902789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani.
    Wolday D; Berhe N; Britton S; Akuffo H
    AIDS; 2000 May; 14(8):921-9. PubMed ID: 10853973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Leishmania homologue of receptors for activated C-kinase (LACK) induces both interferon-gamma and interleukin-10 in natural killer cells of healthy blood donors.
    Maasho K; Satti I; Nylén S; Guzman G; Koning F; Akuffo H
    J Infect Dis; 2000 Aug; 182(2):570-8. PubMed ID: 10915091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of amastigote reactive cells in human cutaneous leishmaniasis caused by Leishmania aethiopica.
    Maasho K; McMahon-Pratt D; Raita J; Raud M; Britton S; Soong L; Akuffo H
    Clin Exp Immunol; 2003 May; 132(2):316-22. PubMed ID: 12699423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-4 and interferon-gamma production by Leishmania stimulated peripheral blood mononuclear cells from nonexposed individuals.
    Kurtzhals JA; Kemp M; Poulsen LK; Hansen MB; Kharazmi A; Theander TG
    Scand J Immunol; 1995 Apr; 41(4):343-9. PubMed ID: 7899822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis.
    Kemp M; Hey AS; Kurtzhals JA; Christensen CB; Gaafar A; Mustafa MD; Kordofani AA; Ismail A; Kharazmi A; Theander TG
    Clin Exp Immunol; 1994 Jun; 96(3):410-5. PubMed ID: 8004809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.
    Skeiky YA; Guderian JA; Benson DR; Bacelar O; Carvalho EM; Kubin M; Badaro R; Trinchieri G; Reed SG
    J Exp Med; 1995 Apr; 181(4):1527-37. PubMed ID: 7699334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD; Locksley RM; Tubbs C; Raff HV
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness in diffuse versus local cutaneous leishmaniasis is due to parasite differences.
    Akuffo H; Schurr E; Andersson G; Yamaneberhan T; Britton S
    Scand J Immunol; 1987 Dec; 26(6):717-21. PubMed ID: 3122314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells in cross-regulation of IL-12 by IL-10 in Leishmania antigen-stimulated blood donor cells.
    Akuffo H; Alexis A; Eidsmo L; Saed A; Nylén S; Maasho K
    Clin Exp Immunol; 1999 Sep; 117(3):529-34. PubMed ID: 10469058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
    Bottrel RL; Dutra WO; Martins FA; Gontijo B; Carvalho E; Barral-Netto M; Barral A; Almeida RP; Mayrink W; Locksley R; Gollob KJ
    Infect Immun; 2001 May; 69(5):3232-9. PubMed ID: 11292745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmanial amastigote antigen P-2 induces major histocompatibility complex class II-dependent natural killer-cell reactivity in cells from healthy donors.
    Nylén S; Maasho K; McMahon-Pratt D; Akuffo H
    Scand J Immunol; 2004 Mar; 59(3):294-304. PubMed ID: 15030581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the protective potential of antigens released by Leishmania (Viannia) shawi promastigotes.
    Passero LF; Marques C; Vale-Gato I; Corbett CE; Laurenti MD; Santos-Gomes G
    Arch Dermatol Res; 2012 Jan; 304(1):47-55. PubMed ID: 21882046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.